Dr Adam Lee Woelk, MD | |
602 Chase Ave, Cordova, AK 99547 | |
(907) 424-8200 | |
(907) 424-8203 |
Full Name | Dr Adam Lee Woelk |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 11 Years |
Location | 602 Chase Ave, Cordova, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912340597 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Cordova Community Medical Center | Cordova, AK | Hospital |
Bristol Bay Area Health Corporation | Dillingham, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cordova Community Medical Center | 1759275902 | 9 |
News Archive
A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.
In this Kaiser Health News video, Greg Millett, a senior policy advisor in the Office of National AIDS Policy, tells Joanne Silberner that the president's National HIV/AIDS Strategy has improved coordination among federal agencies and that the 2010 health law will improve access to care for those living with HIV/AIDS.
Can a patient who agrees to participate in a safety study of a gene therapy protocol give truly informed consent and understand the risks involved when the consent forms are highly technical and the physician or institution seeking their consent has a stake in the study and its outcome?
Chromatin Inc. has announced that it has entered into a research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin's proprietary gene stacking technology.
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.
› Verified 3 days ago
Entity Name | Cordova Community Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215035787 PECOS PAC ID: 1759275902 Enrollment ID: O20040210000439 |
News Archive
A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.
In this Kaiser Health News video, Greg Millett, a senior policy advisor in the Office of National AIDS Policy, tells Joanne Silberner that the president's National HIV/AIDS Strategy has improved coordination among federal agencies and that the 2010 health law will improve access to care for those living with HIV/AIDS.
Can a patient who agrees to participate in a safety study of a gene therapy protocol give truly informed consent and understand the risks involved when the consent forms are highly technical and the physician or institution seeking their consent has a stake in the study and its outcome?
Chromatin Inc. has announced that it has entered into a research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin's proprietary gene stacking technology.
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Adam Lee Woelk, MD 1299 Kekuanaoa St Unit 5482, Hilo, HI 96720-0138 Ph: (907) 744-6443 | Dr Adam Lee Woelk, MD 602 Chase Ave, Cordova, AK 99547 Ph: (907) 424-8200 |
News Archive
A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.
In this Kaiser Health News video, Greg Millett, a senior policy advisor in the Office of National AIDS Policy, tells Joanne Silberner that the president's National HIV/AIDS Strategy has improved coordination among federal agencies and that the 2010 health law will improve access to care for those living with HIV/AIDS.
Can a patient who agrees to participate in a safety study of a gene therapy protocol give truly informed consent and understand the risks involved when the consent forms are highly technical and the physician or institution seeking their consent has a stake in the study and its outcome?
Chromatin Inc. has announced that it has entered into a research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin's proprietary gene stacking technology.
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.
› Verified 3 days ago
Brian Iutzi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Ilanka Clinic, 705 2nd Street, Cordova, AK 99574 Phone: 907-424-3622 |